China-based Luye Pharma Group (HKG: 2186) has announced that its controlling subsidiary, Shandong Boan Biotechnology Co., Ltd, has entered into a partnership with compatriot firm Shanghai Pharmaceutical Group (Benxi) North Pharmaceutical Co., Ltd. The collaboration will focus on the manufacturing of biologic drugs. Financial details of the partnership were not disclosed.
Partnership Overview
Shandong Boan Biotechnology, a biopharma company with an integrated industry chain, is focused on the development, manufacturing, and commercialization of high-quality biologic drugs globally. North Pharmaceutical, on the other hand, is known for its industry-leading antibody and antibody drug conjugate (ADC) manufacturing capabilities in China. The partnership will specifically target the development and production of monoclonal antibodies (mAbs) and ADCs.
Future Outlook
This strategic collaboration aims to leverage the strengths of both companies to enhance the production and commercialization of biologic drugs. By combining Boan Bio’s expertise in drug development with North Pharma’s advanced manufacturing capabilities, the partnership is expected to drive innovation and efficiency in the biopharmaceutical sector.-Fineline Info & Tech
